Trial medication for Crohn’s disease (CD) and Colitis Ulcerosa (CU)

Are you:

• a healthy male
• aged from 18 to 65 years (inclusive)
• with a BMI from 18.5 to 29.9 kg/m²
• non-smoker, ex-smoker or no more than max. 9 cigarettes, 2 cigars or 2 pipes per day 
• not using daily medication

What does this trial involve?

SGS trial BE-80-2100622 investigates the treatment of Crohn’s disease (CD) and Colitis Ulcerosa (CU). During 5 months you will have the following appointments.

• a screening 
• 4-day (3-night) stay 
• 10 short follow-up visits 
• a final examination

Take part in this trial and

• help us develop tomorrow's medicines
• and receive a generous tax-free (in Belgium) payment of € 2300

View information leaflet